دورية أكاديمية

The role of chaperone-mediated autophagy in drug resistance.

التفاصيل البيبلوغرافية
العنوان: The role of chaperone-mediated autophagy in drug resistance.
المؤلفون: Teixeira ABDS; Universidade Federal de São Paulo (UNIFESP), Departamento de Oncologia Clínica e Experimental, São Paulo, SP, Brazil., Ramalho MCC; Universidade Federal de São Paulo (UNIFESP), Departamento de Oncologia Clínica e Experimental, São Paulo, SP, Brazil., Souza I; Universidade Federal de São Paulo (UNIFESP), Departamento de Oncologia Clínica e Experimental, São Paulo, SP, Brazil., Andrade IAM; Universidade Federal de São Paulo (UNIFESP), Departamento de Oncologia Clínica e Experimental, São Paulo, SP, Brazil., Osawa IYA; Universidade Federal de São Paulo (UNIFESP), Departamento de Oncologia Clínica e Experimental, São Paulo, SP, Brazil., Guedes CB; Universidade Federal de São Paulo (UNIFESP), Departamento de Oncologia Clínica e Experimental, São Paulo, SP, Brazil., Oliveira BS; Universidade Federal de São Paulo (UNIFESP), Departamento de Oncologia Clínica e Experimental, São Paulo, SP, Brazil., Souza Filho CHD; Universidade Federal de São Paulo (UNIFESP), Departamento de Oncologia Clínica e Experimental, São Paulo, SP, Brazil., Silva TLD; Universidade Federal de São Paulo (UNIFESP), Departamento de Oncologia Clínica e Experimental, São Paulo, SP, Brazil., Moreno NC; National Institutes of Health, National Institute of Child Health and Human Development, Laboratory of Genomic Integrity, Bethesda, MD, USA., Latancia MT; National Institutes of Health, National Institute of Child Health and Human Development, Laboratory of Genomic Integrity, Bethesda, MD, USA., Rocha CRR; Universidade Federal de São Paulo (UNIFESP), Departamento de Oncologia Clínica e Experimental, São Paulo, SP, Brazil.
المصدر: Genetics and molecular biology [Genet Mol Biol] 2024 May 31; Vol. 47 (Suppl 1), pp. e20230317. Date of Electronic Publication: 2024 May 31 (Print Publication: 2024).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Sociedade Brasileira de Genética Country of Publication: Brazil NLM ID: 100883590 Publication Model: eCollection Cited Medium: Print ISSN: 1415-4757 (Print) Linking ISSN: 14154757 NLM ISO Abbreviation: Genet Mol Biol Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Ribeirão Preto, SP, Brazil : Sociedade Brasileira de Genética, 1998-
مستخلص: In the search for alternatives to overcome the challenge imposed by drug resistance development in cancer treatment, the modulation of autophagy has emerged as a promising alternative that has achieved good results in clinical trials. Nevertheless, most of these studies have overlooked a novel and selective type of autophagy: chaperone-mediated autophagy (CMA). Following its discovery, research into CMA's contribution to tumor progression has accelerated rapidly. Therefore, we now understand that stress conditions are the primary signal responsible for modulating CMA in cancer cells. In turn, the degradation of proteins by CMA can offer important advantages for tumorigenesis, since tumor suppressor proteins are CMA targets. Such mutual interaction between the tumor microenvironment and CMA also plays a crucial part in establishing therapy resistance, making this discussion the focus of the present review. Thus, we highlight how suppression of LAMP2A can enhance the sensitivity of cancer cells to several drugs, just as downregulation of CMA activity can lead to resistance in certain cases. Given this panorama, it is important to identify selective modulators of CMA to enhance the therapeutic response.
References: Thorac Cancer. 2021 Apr;12(7):1048-1057. (PMID: 33566442)
Biochem J. 2003 Oct 1;375(Pt 1):75-86. (PMID: 12841850)
Trends Cancer. 2018 Feb;4(2):110-118. (PMID: 29458961)
Front Cell Dev Biol. 2018 Sep 10;6:104. (PMID: 30250843)
Cell Res. 2014 Jan;24(1):9-23. (PMID: 24366340)
Nat Commun. 2015 Apr 16;6:6823. (PMID: 25880015)
Curr Mol Pharmacol. 2012 Jan;5(1):102-14. (PMID: 22122467)
Cell Mol Life Sci. 2011 Mar;68(5):749-63. (PMID: 20976518)
Lancet. 2017 Sep 16;390(10100):1151-1210. (PMID: 28919116)
Autophagy. 2014 Feb;10(2):384-5. (PMID: 24362353)
Mol Cancer Res. 2014 Apr;12(4):485-90. (PMID: 24478461)
Curr Opin Cell Biol. 2010 Apr;22(2):124-31. (PMID: 20034776)
Mol Cancer. 2023 Jun 15;22(1):96. (PMID: 37322433)
Adv Pharm Bull. 2017 Sep;7(3):339-348. (PMID: 29071215)
PLoS One. 2016 Sep 14;11(9):e0162977. (PMID: 27627761)
Genes Dev. 2013 Aug 1;27(15):1718-30. (PMID: 23913924)
Br J Cancer. 2016 Jul 26;115(3):312-21. (PMID: 27380135)
Oncol Rep. 2022 Apr;47(4):. (PMID: 35211759)
Curr Oncol. 2022 Mar 05;29(3):1695-1708. (PMID: 35323341)
Bioorg Med Chem. 2008 Sep 1;16(17):7888-93. (PMID: 18691894)
J Clin Invest. 2003 Dec;112(12):1809-20. (PMID: 14638851)
Mol Biol Cell. 2004 Nov;15(11):4829-40. (PMID: 15331765)
Clinics (Sao Paulo). 2018 Sep 06;73(suppl 1):e478s. (PMID: 30208165)
Methods Mol Biol. 2008;445:1-10. (PMID: 18425440)
Trends Endocrinol Metab. 2020 Jan;31(1):53-66. (PMID: 31699565)
Cell Commun Signal. 2022 Jun 30;20(1):100. (PMID: 35773670)
Nat Commun. 2017 Nov 24;8(1):1763. (PMID: 29176575)
Front Oncol. 2018 Jul 02;8:249. (PMID: 30013951)
Anticancer Agents Med Chem. 2023;23(10):1122-1144. (PMID: 35598250)
Cancer Lett. 2017 Aug 1;400:183-193. (PMID: 28465257)
Cancer Lett. 1994 Jul 15;82(1):27-32. (PMID: 7518342)
EMBO J. 2017 Jul 3;36(13):1811-1836. (PMID: 28596378)
Ageing Res Rev. 2021 Dec;72:101468. (PMID: 34563704)
Nature. 2019 Nov;575(7782):299-309. (PMID: 31723286)
Cell Death Differ. 2010 Aug;17(8):1277-87. (PMID: 20150913)
Biomed Pharmacother. 2021 Feb;134:111095. (PMID: 33341048)
Genes Dev. 2016 Aug 1;30(15):1704-17. (PMID: 27516533)
J Biol Chem. 2001 Nov 16;276(46):43407-12. (PMID: 11557773)
Autophagy. 2012 Nov;8(11):1643-56. (PMID: 22874552)
J Cell Sci. 2001 Jul;114(Pt 13):2491-9. (PMID: 11559757)
Transl Neurodegener. 2014 Sep 21;3:20. (PMID: 25276349)
Trends Biochem Sci. 1990 Aug;15(8):305-9. (PMID: 2204156)
Biochem Biophys Res Commun. 2015 May 29;461(2):268-74. (PMID: 25887800)
Nat Immunol. 2014 Nov;15(11):1046-54. (PMID: 25263126)
Front Aging Neurosci. 2021 Jan 28;12:630743. (PMID: 33633561)
Med Oncol. 2022 Jul 14;39(10):149. (PMID: 35834030)
Autophagy. 2017 May 4;13(5):928-940. (PMID: 28410006)
Am J Physiol. 1995 Nov;269(5 Pt 1):C1200-8. (PMID: 7491910)
Br J Pharmacol. 2023 Jun 13;:. (PMID: 37311689)
Genes Cancer. 2010 Jul;1(7):708-16. (PMID: 21779466)
Int J Gen Med. 2022 Jun 15;15:5635-5649. (PMID: 35734200)
Int J Cancer. 2016 Jul 1;139(1):23-32. (PMID: 26757106)
Nat Chem Biol. 2013 Jun;9(6):374-82. (PMID: 23584676)
Redox Biol. 2023 Nov;67:102872. (PMID: 37688978)
Cells. 2022 Aug 17;11(16):. (PMID: 36010638)
Cells. 2019 Oct 24;8(11):. (PMID: 31653091)
Mol Cell Biol. 2008 Sep;28(18):5747-63. (PMID: 18644871)
FEBS J. 2016 Jul;283(13):2403-13. (PMID: 26854402)
Cell Res. 2014 Jan;24(1):24-41. (PMID: 24366339)
Mol Cell Biol. 2003 Jan;23(1):359-69. (PMID: 12482987)
Essays Biochem. 2016 Oct 15;60(2):173-180. (PMID: 27744333)
Nat Rev Mol Cell Biol. 2018 Jun;19(6):365-381. (PMID: 29626215)
Arzneimittelforschung. 2008;58(6):261-4. (PMID: 18677966)
Cancer Cell. 2013 Aug 12;24(2):213-228. (PMID: 23911236)
Leuk Lymphoma. 2000 Oct;39(3-4):271-82. (PMID: 11342307)
J Biol Chem. 1985 Oct 5;260(22):11986-93. (PMID: 4044585)
Elife. 2017 Jan 17;6:. (PMID: 28094001)
Cells. 2019 Oct 16;8(10):. (PMID: 31623164)
Biochimie. 2014 Dec;107 Pt B:338-49. (PMID: 25308836)
J Clin Invest. 2015 Jan;125(1):42-6. (PMID: 25654549)
Aging Cell. 2022 Jun;21(6):e13616. (PMID: 35535673)
Oncogene. 2018 Nov;37(45):5997-6009. (PMID: 29985480)
J Cell Mol Med. 2011 Jun;15(6):1402-14. (PMID: 20626525)
Curr Mol Med. 2013 May;13(4):543-54. (PMID: 22950383)
Mol Cell Oncol. 2014 Jul 15;1(1):e29911. (PMID: 27308318)
Aging Cell. 2015 Apr;14(2):249-64. (PMID: 25620427)
Semin Cell Dev Biol. 2010 Sep;21(7):719-26. (PMID: 20176123)
Nat Rev Cancer. 2013 Oct;13(10):714-26. (PMID: 24060863)
PLoS One. 2011;6(9):e25268. (PMID: 21966475)
Science. 1976 Oct 1;194(4260):23-8. (PMID: 959840)
Antioxid Redox Signal. 2014 Jan 20;20(3):460-73. (PMID: 23725295)
Exp Cell Res. 2010 Jul 15;316(12):1914-24. (PMID: 20184880)
Pharmacol Ther. 2020 Feb;206:107447. (PMID: 31756363)
J Clin Invest. 2008 Dec;118(12):3837-40. (PMID: 19033653)
Annu Rev Physiol. 1966;28:435-92. (PMID: 5322983)
Cancer Treat Rev. 2020 Aug;88:102043. (PMID: 32505806)
Science. 1996 Jul 26;273(5274):501-3. (PMID: 8662539)
Oncotarget. 2017 May 3;8(31):51970-51985. (PMID: 28881704)
Science. 1989 Oct 20;246(4928):382-5. (PMID: 2799391)
Autophagy. 2023 Jan;19(1):152-162. (PMID: 35435804)
Nature. 2020 May;581(7806):100-105. (PMID: 32376951)
J Biosci. 2006 Mar;31(1):137-55. (PMID: 16595883)
Sci Rep. 2017 Jul 6;7(1):4759. (PMID: 28684853)
Sci Adv. 2020 Apr 29;6(18):eaax7881. (PMID: 32494661)
World J Gastroenterol. 2017 Apr 7;23(13):2308-2317. (PMID: 28428710)
Cancer Sci. 2020 Nov;111(11):4154-4165. (PMID: 32860290)
Cell. 2009 Jun 12;137(6):1062-75. (PMID: 19524509)
Cells. 2020 Apr 14;9(4):. (PMID: 32295144)
Autophagy. 2011 Jul;7(7):673-82. (PMID: 21646866)
Oncotarget. 2017 Jul 11;8(28):46663-46680. (PMID: 28445146)
Adv Exp Med Biol. 2021;1208:333-356. (PMID: 34260032)
Nature. 1999 Dec 9;402(6762):672-6. (PMID: 10604474)
Cell Death Dis. 2013 Oct 10;4:e838. (PMID: 24113172)
Biomedicines. 2023 Apr 03;11(4):. (PMID: 37189700)
Front Genet. 2019 Sep 25;10:868. (PMID: 31608113)
Neurosci Bull. 2022 Jun;38(6):637-651. (PMID: 35267139)
J Mol Cell Biol. 2020 Sep 1;12(9):700-712. (PMID: 32285119)
Front Oncol. 2022 Jun 23;12:891652. (PMID: 35814435)
Curr Neuropharmacol. 2021;19(4):513-537. (PMID: 32589560)
Biochim Biophys Acta. 2014 Jan;1845(1):84-9. (PMID: 24361676)
Mol Cell. 2015 Jul 16;59(2):270-84. (PMID: 26118642)
J Cell Biol. 2015 Aug 31;210(5):705-16. (PMID: 26323688)
Cell Res. 2014 Jan;24(1):92-104. (PMID: 24281265)
Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5805-10. (PMID: 16585521)
Free Radic Biol Med. 2014 Jun;71:196-207. (PMID: 24681256)
Autophagy. 2018;14(8):1310-1322. (PMID: 29950142)
Mol Med Rep. 2021 May;23(5):. (PMID: 33760140)
Biochim Biophys Acta. 2003 Mar 17;1603(2):113-28. (PMID: 12618311)
Int J Mol Sci. 2021 Feb 23;22(4):. (PMID: 33672324)
Autophagy. 2005 Oct-Dec;1(3):141-5. (PMID: 16874031)
Int J Mol Sci. 2017 Nov 07;18(11):. (PMID: 29112132)
Int J Mol Sci. 2022 Jun 21;23(13):. (PMID: 35805884)
Front Oncol. 2021 Feb 12;10:614677. (PMID: 33643916)
J Cell Physiol. 2015 Feb;230(2):259-71. (PMID: 25196387)
Curr Pharmacol Rep. 2018 Jun;4(3):261-275. (PMID: 34540559)
Sci Transl Med. 2011 Nov 16;3(109):109ra117. (PMID: 22089453)
J Biol Chem. 2018 Apr 13;293(15):5414-5424. (PMID: 29247007)
Eur J Pharmacol. 2014 Oct 5;740:364-78. (PMID: 25058905)
Cells. 2020 Sep 22;9(9):. (PMID: 32971884)
Methods. 2015 Mar;75:133-40. (PMID: 25595300)
Mol Cell. 2011 Jun 24;42(6):719-30. (PMID: 21700219)
تواريخ الأحداث: Date Created: 20240603 Latest Revision: 20240607
رمز التحديث: 20240607
مُعرف محوري في PubMed: PMC11145944
DOI: 10.1590/1678-4685-GMB-2023-0317
PMID: 38829285
قاعدة البيانات: MEDLINE
الوصف
تدمد:1415-4757
DOI:10.1590/1678-4685-GMB-2023-0317